EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities

Moslem Javidan, Zahra Jafari, Shahdokht Abbasiniya, Sirous Jamalzehi, Afsaneh Shafiei, Ali Khodadadi

Oncology and Therapy · 2026-06 · 14 (2) · 543-573

DOI: 10.1007/s40487-026-00444-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology and Therapy, online erschienen am 22.05.2026. Verfasst von Moslem Javidan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Immunometabolic reprogrammingLactate trappingMCT1/MCT4 inhibitionSynthetic lethalitySyrosingopineTumor metabolism

Autor:innen und Institutionen

  • Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Tropical and Communicable Diseases Research Center, Iranshahr University of Medical Sciences, Iranshahr, Iran.
  • Student Research Committee, Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Department of Immunology, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Student Research Committee, School of Medicine, Iranshahr, Iran.
  • Department of Medical Laboratory Sciences, Iranshahr University of Medical Sciences, Iranshahr, Iran.

Zitieren

APA

Javidan, M., Jafari, Z., Abbasiniya, S., Jamalzehi, S., Shafiei, A., & Khodadadi, A. (2026). Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities. Oncology and Therapy, 14(2), 543-573. https://doi.org/10.1007/s40487-026-00444-9

Vancouver

Javidan M, Jafari Z, Abbasiniya S, Jamalzehi S, Shafiei A, Khodadadi A. Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities. Oncology and Therapy. 2026;14(2):543-573. doi:10.1007/s40487-026-00444-9

BibTeX
@article{Javidan2026,
  author = {Javidan, Moslem and Jafari, Zahra and Abbasiniya, Shahdokht and Jamalzehi, Sirous and Shafiei, Afsaneh and Khodadadi, Ali},
  title = {Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities},
  journal = {Oncology and Therapy},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {543--573},
  doi = {10.1007/s40487-026-00444-9}
}
Kostenlos starten →